(3S,4E,12Z,20R,23E,27Z,42E,44S)-hexatetraconta-4,12,23,27,42-pentaen-1,18,21,45-tetrayne-3,20,44-triol

Details

Top
Internal ID 36f9e7de-e658-4c03-bdef-7ed5007ecec8
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty alcohols
IUPAC Name (3S,4E,12Z,20R,23E,27Z,42E,44S)-hexatetraconta-4,12,23,27,42-pentaen-1,18,21,45-tetrayne-3,20,44-triol
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C46H68O3/c1-3-44(47)40-36-32-28-24-20-16-12-10-8-6-5-7-9-11-13-18-22-26-30-34-38-42-46(49)43-39-35-31-27-23-19-15-14-17-21-25-29-33-37-41-45(48)4-2/h1-2,13,15,18-19,30,34,36-37,40-41,44-49H,5-12,14,16-17,20-29,31-33,35H2/b18-13-,19-15-,34-30+,40-36+,41-37+/t44-,45-,46+/m1/s1
InChI Key JMDLXSJNUCOOQN-LPRLOCBRSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C46H68O3
Molecular Weight 669.00 g/mol
Exact Mass 668.51684603 g/mol
Topological Polar Surface Area (TPSA) 60.70 Ų
XlogP 13.90
Atomic LogP (AlogP) 10.88
H-Bond Acceptor 3
H-Bond Donor 3
Rotatable Bonds 30

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (3S,4E,12Z,20R,23E,27Z,42E,44S)-hexatetraconta-4,12,23,27,42-pentaen-1,18,21,45-tetrayne-3,20,44-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9338 93.38%
Caco-2 - 0.8344 83.44%
Blood Brain Barrier + 0.6000 60.00%
Human oral bioavailability - 0.7429 74.29%
Subcellular localzation Mitochondria 0.6722 67.22%
OATP2B1 inhibitior - 0.8574 85.74%
OATP1B1 inhibitior + 0.8359 83.59%
OATP1B3 inhibitior + 0.9500 95.00%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior + 0.9392 93.92%
P-glycoprotein inhibitior + 0.7025 70.25%
P-glycoprotein substrate - 0.8365 83.65%
CYP3A4 substrate + 0.5163 51.63%
CYP2C9 substrate - 0.6095 60.95%
CYP2D6 substrate - 0.7375 73.75%
CYP3A4 inhibition - 0.8409 84.09%
CYP2C9 inhibition - 0.7289 72.89%
CYP2C19 inhibition - 0.8290 82.90%
CYP2D6 inhibition - 0.9457 94.57%
CYP1A2 inhibition - 0.7315 73.15%
CYP2C8 inhibition - 0.5902 59.02%
CYP inhibitory promiscuity - 0.5869 58.69%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.6023 60.23%
Carcinogenicity (trinary) Non-required 0.5698 56.98%
Eye corrosion + 0.8384 83.84%
Eye irritation - 0.8855 88.55%
Skin irritation + 0.5123 51.23%
Skin corrosion - 0.6656 66.56%
Ames mutagenesis - 0.6700 67.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8480 84.80%
Micronuclear - 0.9300 93.00%
Hepatotoxicity - 0.5162 51.62%
skin sensitisation + 0.6335 63.35%
Respiratory toxicity - 0.5111 51.11%
Reproductive toxicity - 0.8444 84.44%
Mitochondrial toxicity - 0.6375 63.75%
Nephrotoxicity - 0.6930 69.30%
Acute Oral Toxicity (c) III 0.6424 64.24%
Estrogen receptor binding + 0.7416 74.16%
Androgen receptor binding - 0.5906 59.06%
Thyroid receptor binding - 0.5156 51.56%
Glucocorticoid receptor binding + 0.5545 55.45%
Aromatase binding + 0.5901 59.01%
PPAR gamma + 0.5811 58.11%
Honey bee toxicity - 0.8053 80.53%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity + 0.5400 54.00%
Fish aquatic toxicity + 0.7142 71.42%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.32% 91.11%
CHEMBL3975 P09467 Fructose-1,6-bisphosphatase 93.77% 92.95%
CHEMBL3060 Q9Y345 Glycine transporter 2 91.04% 99.17%
CHEMBL221 P23219 Cyclooxygenase-1 90.04% 90.17%
CHEMBL4657 Q6V1X1 Dipeptidyl peptidase VIII 87.67% 97.21%
CHEMBL2581 P07339 Cathepsin D 87.20% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.43% 96.09%
CHEMBL3145 P42338 PI3-kinase p110-beta subunit 81.29% 98.75%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 163190228
LOTUS LTS0021542
wikiData Q105131279